The ISIDORe consortium has recently launched its first call to support research on SARS-CoV-2 and COVID-19. It provides free of charge access to more than 300 services from ISIDORe’s integrated portfolio of cutting-edge research services dedicated to epidemic-prone disease research.
It will follow in coming weeks with a new access call dedicated to the Monkeypox virus.